Jonathan C. Javitt - May 24, 2021 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Jonathan C. Javitt
Stock symbol
NRXP
Transactions as of
May 24, 2021
Transactions value $
$0
Form type
3
Date filed
6/10/2021, 06:32 PM
Next filing
Jun 2, 2022

No securities are beneficially owned.